Immunogenicity of the DNA/Protein Combined Vaccine against COVID-19

被引：1
|
作者：
Borgoyakova, M. B. [1 ]
Karpenko, L. I. [1 ]
Merkulyeva, I. A. [1 ]
Shcherbakov, D. N. [1 ]
Rudometov, A. P. [1 ]
Starostina, E. V. [1 ]
Shanshin, D. V. [1 ]
Isaeva, A. A. [1 ]
Nesmeyanova, V. S. [1 ]
Volkova, N. V. [1 ]
Belenkaya, S. V. [1 ]
Volosnikova, E. A. [1 ]
Zadorozhny, A. M. [1 ]
Orlova, L. A. [1 ]
Zaykovskaya, A. V. [1 ]
Pyankov, O. V. [1 ]
Bazhan, S. I. [1 ]
Ilyichev, A. A. [1 ]
机构：
[1] Fed Serv Oversight Consumer Protect & Welf, State Res Ctr Virol & Biotechnol VECTOR, Koltsov, Novosibirsk Reg, Russia
来源：
BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE | 2022年 / 174卷 / 02期
关键词：
SARS-CoV-2; DNA vaccines; subunit vaccines; DNA; protein vaccines; immune response;
D O I：
10.1007/s10517-023-05682-9
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
During the COVID-19 pandemic, the development of prophylactic vaccines, including those based on new platforms, became highly relevant. One such platform is the creation of vaccines combining DNA and protein components in one construct. For the creation of DNA vaccine, we chose the full-length spike protein (S) of the SARS-CoV-2 virus and used the recombinant receptor-binding domain (RBD) of the S protein produced in CHO-K1 cells as a protein component. The immunogenicity of the developed combined vaccine and its individual components was compared and the contribution of each component to the induction of the immune response was analyzed. The combined DNA/protein vaccine possesses the advantages of both underlying approaches and is capable of inducing both humoral (similar to subunit vaccines) and cellular (similar to DNA vaccines) immunity.
引用
收藏
页码：246 / 249
页数：4
相关论文
共 50 条
  • [31] A promising vaccine candidate against COVID-19
    Xiwei Wang
    Wenwei Tu
    Molecular Biomedicine, 1
  • [32] Heterologous vaccine regimens against COVID-19
    Duarte-Salles, Talita
    Prieto-Alhambra, Daniel
    LANCET, 2021, 398 (10295): : 94 - 95
  • [33] Status of vaccine development against covid-19
    Taxt, Arne Michael
    Grodeland, Gunnveig
    Lind, Andreas
    Mueller, Fredrik
    TIDSSKRIFT FOR DEN NORSKE LAEGEFORENING, 2020, 140 (13) : 1328 - 1334
  • [34] A promising vaccine candidate against COVID-19
    Wang, Xiwei
    Tu, Wenwei
    MOLECULAR BIOMEDICINE, 2020, 1 (01):
  • [35] Inoculating against COVID-19 vaccine misinformation
    van der Linden, Sander
    Dixon, Graham
    Clarke, Chris
    Cook, John
    ECLINICALMEDICINE, 2021, 33
  • [36] A Thermostable mRNA Vaccine against COVID-19
    Zhang, Na-Na
    Li, Xiao-Feng
    Deng, Yong-Qiang
    Zhao, Hui
    Huang, Yi-Jiao
    Yang, Guan
    Huang, Wei-Jin
    Gao, Peng
    Zhou, Chao
    Zhang, Rong-Rong
    Guo, Yan
    Sun, Shi-Hui
    Fan, Hang
    Zu, Shu-Long
    Chen, Qi
    He, Qi
    Cao, Tian-Shu
    Huang, Xing-Yao
    Qiu, Hong-Ying
    Nie, Jian-Hui
    Jiang, Yuhang
    Yan, Hua-Yuan
    Ye, Qing
    Zhong, Xia
    Xue, Xia-Lin
    Zha, Zhen-Yu
    Zhou, Dongsheng
    Yang, Xiao
    Wang, You-Chun
    Ying, Bo
    Qin, Cheng-Feng
    CELL, 2020, 182 (05) : 1271 - +
  • [37] Low toxicity and high immunogenicity of an inactivated vaccine candidate against COVID-19 in different animal models
    Wang, Ze-Jun
    Zhang, Hua-Jun
    Lu, Jia
    Xu, Kang-Wei
    Peng, Cheng
    Guo, Jing
    Gao, Xiao-Xiao
    Wan, Xin
    Wang, Wen-Hui
    Shan, Chao
    Zhang, Su-Cai
    Wu, Jie
    Yang, An-Na
    Zhu, Yan
    Xiao, Ao
    Zhang, Lei
    Fu, Lie
    Si, Hao-Rui
    Cai, Qian
    Yang, Xing-Lou
    You, Lei
    Zhou, Yan-Ping
    Liu, Jing
    Pang, De-Qing
    Jin, Wei-Ping
    Zhang, Xiao-Yu
    Meng, Sheng-Li
    Sun, Yun-Xia
    Desselberger, Ulrich
    Wang, Jun-Zhi
    Li, Xin-Guo
    Duan, Kai
    Li, Chang-Gui
    Xu, Miao
    Shi, Zheng-Li
    Yuan, Zhi-Ming
    Yang, Xiao-Ming
    Shen, Shuo
    EMERGING MICROBES & INFECTIONS, 2020, 9 (01) : 2606 - 2618
  • [38] Immunogenicity Evaluating of the Multivalent COVID-19 Inactivated Vaccine against the SARS-CoV-2 Variants
    Zhang, Yuntao
    Tan, Wenjie
    Lou, Zhiyong
    Huang, Baoying
    Zhou, Weimin
    Zhao, Yuxiu
    Zhang, Jin
    Liang, Hongyang
    Li, Na
    Zhu, Xiujuan
    Ding, Ling
    Guo, Yancen
    He, Zhenyu
    He, Yao
    Wang, Zhanhui
    Ma, Bo
    Ma, Meng
    Zhao, Suhua
    Chang, Zhen
    Zhao, Xue
    Zheng, Xiaotong
    Wu, Guizhen
    Wang, Hui
    Yang, Xiaoming
    VACCINES, 2022, 10 (06)
  • [39] Immunogenicity of the Xcl1-SARS-CoV-2 Spike Fusion DNA Vaccine for COVID-19
    Qi, Hailong
    Sun, Zhongjie
    Yao, Yanling
    Chen, Ligong
    Su, Xuncheng
    VACCINES, 2022, 10 (03)
  • [40] Immunogenicity and protection efficacy of a COVID-19 DNA vaccine encoding spike protein with D614G mutation and optimization of large-scale DNA vaccine production
    Gul, Aytul
    Alak, Sedef Erkunt
    Can, Huseyin
    Karakavuk, Muhammet
    Korukluoglu, Gulay
    Altas, Ayse Basak
    Gul, Ceren
    Karakavuk, Tugba
    Koseoglu, Ahmet Efe
    Polat, Hivda Ulbegi
    Malkocoglu, Hilal Yazici
    Ekiz, Arzu Tas
    Abaci, Irem
    Aksoy, Ozge
    Enul, Hakan
    Adiay, Cumhur
    Uzar, Serdar
    Sarac, Fahriye
    Un, Cemal
    Guruz, Adnan Yuksel
    Kantarci, Ayse Gulten
    Akbaba, Hasan
    Akbaba, Gulsah Erel
    Yilmaz, Habibe
    Doskaya, Aysu Degirmenci
    Tasbakan, Meltem
    Pullukcu, Husnu
    Karasulu, Ercument
    Tekin, Saban
    Doskaya, Mert
    SCIENTIFIC REPORTS, 2024, 14 (01):
12345